Jorge Espinosa-Espinosa

4PUBLICATIONS
22CO-AUTHORS
Molecular targetsGene and molecular therapyMedical molecular engineering of nucleic acids and proteinsGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Dec 17, 2024
A Novel Class of FKBP12 Ligands Rescues Premature Aging Phenotypes Associated with Myotonic Dystrophy Type 1.

Mikel García-Puga, Gorka Gerenu, Ariadna Bargiela

|Oct 09, 2024
AntimiR treatment corrects myotonic dystrophy primary cell defects across several CTG repeat expansions with a dual mechanism of action.

Estefanía Cerro-Herreros, Judit Núñez-Manchón, Neia Naldaiz-Gastesi

|Apr 28, 2023
BlockmiR AONs as Site-Specific Therapeutic MBNL Modulation in Myotonic Dystrophy 2D and 3D Muscle Cells and HSALR Mice.

Sarah J Overby, Estefanía Cerro-Herreros, Jorge Espinosa-Espinosa

|Feb 15, 2022
Deciphering the Complex Molecular Pathogenesis of Myotonic Dystrophy Type 1 through Omics Studies.

Jorge Espinosa-Espinosa, Anchel González-Barriga, Arturo López-Castel

Pageof 1

Frequent Collaborators

4 joint publications

Rubén Artero

2 joint publications

Irene González-Martínez

1 joint publications

Arturo López-Castel

1 joint publications

Sarah J Overby